Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
SWITZERLAND –Novartis has announced a new organizational structure and operating model with the goal of achieving US$1 billion in cost savings by 2024, as well as changes in executive leadership…
Read More
SWITZERLAND – Sandoz, a Novartis division, has acquired Coalesce Product Development Limited, a medical and drug delivery device development company based in the United Kingdom. Sandoz has acquired Coalesce’s capabilities…
Read More
SWITZERLAND – Voyager Therapeutics has secured a license option agreement in a potentially US$1.8 billion deal with Novartis. Novartis will be able to use the gene therapy company’s capsid discovery…
Read More
SOUTH AFRICA – South African pharmaceutical Aspen has finalized an agreement with Switzerland Acino Pharma AG for Acino to acquire six South African prescription medicines from Pharmacare Limited, a subsidiary…
Read More
SWITZERLAND – According to the findings of the third round of the World Health Organization’s (WHO) Global Pulse Survey, Health systems are still facing significant challenges in providing essential health…
Read More
SWITZERLAND – Two private equity giants are discussing launching a joint bid for Novartis’ generics unit, Bloomberg has reported. Novartis announced last year that it was conducting a strategic review…
Read More
SWITZERLAND – Roche has outlined a new clinical path forward for tominersen, a closely watched Huntington’s disease drug, ten months after disappointing Phase 3 study results appeared to spell the…
Read More
SWITZERLAND – Roche has announced that its Cobas Pulse system is now available in select European countries that accept CE mark approval. Roche created the Cobas Pulse system to combine…
Read More
SWITZERLAND – Novartis has agreed to pay up to US$1.5 billion for Gyroscope Therapeutics, a U.K.-based ocular gene therapy company, as the pharmaceutical giant seeks to acquire smaller companies with…
Read More
NETHERLANDS – The European Medicines Agency (EMA) has recommended extending the use of Roche’s RoActemra arthritis drug for adult COVID-19 patients receiving systemic steroid treatment and those requiring oxygen support…
Read More